Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve

The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population health. Recent work in the UK estimated, for the f

\"UNITE for Thailand\" is an initiative designed to cultivate the next generation of global health leaders, anchored by the Health Intervention and Technology Assessment Program (HITAP). The proposal acknowledges the critical role of effective leadership in addressing global health challenges and emphasizes the need for proactive support for early

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q

This project aims to support HITAP ’s capacity building strategy through individual capacity development schemes, for instance, participating in academic conferences, or providing an opportunity to work in and learn from other health technology assessment (HTA ) organizations. In addition, this project included international networking with leadi

The project in phase II aims to develop capability in the assessment of health technologies and policies through the activities of capacity building of staff, organization and networks, and to promote the network of the assessment of health technologies and policies in order to make the assessment of health technologies and policies in Thailand as

This study is a development oriented research. The data is collected by participant observation, brainstorming with experts, and a questionnaire asking opinions and the satisfaction from stakeholders attending the meeting of “the prioritization of research topics” on January 22nd, 2010. There was a total of 120 research topics proposed by 66 ag